AI assistant
PLUS THERAPEUTICS, INC. — Director's Dealing 2016
Jan 4, 2016
34301_dirs_2016-01-04_e71275fb-d7c5-4b88-9ce4-6dd708e2e0d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2016-01-04
Reporting Person: Hawkins Richard J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-04 | Incentive Stock Option (Right to Buy) | $ | A | 53820 | Acquired | 2026-01-04 | Common Stock (53820) | Direct |
Footnotes
F1: The reporting person received an incentive stock option granted under the Corporation's 2014 Equity Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised shall be the closing sale price of the Corporation's Common Stock on the NASDAQ Stock Market as of the date of the grant. The closing sale price is $0.1872.
F2: Fifty percent (50%) of the option shares shall vest on January 4, 2017 with the remaining fifty percent (50%) of the option shares vesting on January 4, 2018.